layoffs

Shares of Neon Therapeutics rise on restructuring plans
Shares of Neon Therapeutics rise on restructuring plans
Marketwatch
Neon Therapeutics
layoffs
restructuring
Flag link:
Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales
Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales
Fierce Pharma
Amgen
layoffs
R&D
drug reps
Flag link:
Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development
Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development
BioSpace
Novartis
Shanghai
China
layoffs
R&D
Flag link:
Merck to slash more than 100 R&D jobs from French site: report
Merck to slash more than 100 R&D jobs from French site: report
Fierce Biotech
Merck
France
layoffs
R&D
Flag link:
Amgen to cut 149 staff in retreat from neuroscience R&D
Amgen to cut 149 staff in retreat from neuroscience R&D
Fierce Biotech
Amgen
Neuroscience
layoffs
R&D
Flag link:
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Xconomy
Halozyme Therapeutics
pancreatic cancer
clinical trials
restructuring
layoffs
PEGPH20
Flag link:
With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs
With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs
BioSpace
Cyclerion
clinical trials
praliciguat
diabetic neuropathy
layoffs
Flag link:
Alkermes to lay off 160 in cost-cutting restructure
Alkermes to lay off 160 in cost-cutting restructure
Biopharma Dive
Alkermes
restructuring
layoffs
Flag link:
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Genetic Engineering News
Merck
layoffs
drug reps
Flag link:
Takeda pares down products and jobs, revives Genzyme building plans
Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Takeda
Shire
M&A
layoffs
Flag link:
Eli Lilly to shutter neuroscience R&D center next year
Eli Lilly to shutter neuroscience R&D center next year
Fierce Biotech
Eli Lilly
UK
layoffs
R&D
Flag link:
Five Prime's new CEO wields ax, laying off 70 staffers
Five Prime's new CEO wields ax, laying off 70 staffers
Fierce Biotech
Five Prime Therapeutics
layoffs
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Dynavax continues to shed staffers as CSO to leave with no replacement plan
Dynavax continues to shed staffers as CSO to leave with no replacement plan
Fierce Biotech
Dynavax Technologies
layoffs
Flag link:
After failed cancer test, Tocagen slashes staff
After failed cancer test, Tocagen slashes staff
Fierce Biotech
Tocagen
layoffs
gene therapy
Flag link:
Potential buyers size up Novartis site as layoffs loom for 400 workers
Potential buyers size up Novartis site as layoffs loom for 400 workers
Fierce Pharma
Novartis
drug manufacturing
layoffs
Flag link:
Daiichi Sankyo to cut 69 opioid sales jobs
Daiichi Sankyo to cut 69 opioid sales jobs
Beckers Hospital Review
Daiichi Sankyo
opioids
layoffs
drug reps
Flag link:
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Fierce Biotech
Inovio
layoffs
bladder cancer
diagnostics
Flag link:
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Fierce Biotech
Immunogen
R&D
layoffs
Flag link:
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
AbbVie
Allergan
M&A
R&D
layoffs
Flag link:

Pages